Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
Neurosci Lett. 2020 Sep 25;736:135277. doi: 10.1016/j.neulet.2020.135277. Epub 2020 Jul 30.
Diabetic peripheral neuropathic pain (DPNP), the most debilitating complication of diabetes mellitus, is resistant to current therapy. The pathogenesis of DPNP is still elusive, but several mechanisms have been proposed including abnormal hyperexcitability of dorsal root ganglion (DRG) neurons. The underlying molecular mechanisms of such aberrant hyperexcitability are incompletely understood. Using the streptozotocin (STZ) rat model of DPNP, we have recently provided evidence implicating neuronal K7 channels that normally exert a powerful stabilizing influence on neuronal excitability, in the abnormal hyperexcitability of DRG neurons and in pain hypersensitivity associated with DPNP. In the present immunohistochemical study, we sought to determine whether K7.2 and/or K7.5 channel expression is altered in DRG neurons in STZ rats. We found 35 days post-STZ: (1) a significant decrease in K7.5-immunoreactivity in small (<30 μm) DRG neurons (both IB4 positive and IB4 negative) and medium-sized (30-40 μm) neurons, and (2) a significant increase in K7.2-immunoreactivity in small (<30 μm) neurons, and a non-significant increase in medium/large neurons. The decrease in K7.5 channel expression in small and medium-sized DRG neurons in STZ rats is likely to contribute to the mechanisms of hyperexcitability of these neurons and thereby to the resulting pain hypersensitivity associated with DPNP. The upregulation of K7.2 subunit in small DRG neurons may be an activity dependent compensatory mechanism to limit STZ-induced hyperexcitability of DRG neurons and the associated pain hypersensitivity. The findings support the notion that K7 channels may represent a novel target for DPNP treatment.
糖尿病周围神经病理性疼痛(DPNP)是糖尿病最具致残性的并发症,目前的治疗方法对此收效甚微。DPNP 的发病机制仍难以捉摸,但已提出几种机制,包括背根神经节(DRG)神经元的异常过度兴奋。这种异常过度兴奋的潜在分子机制尚不完全清楚。我们最近使用链脲佐菌素(STZ)诱导的 DPNP 大鼠模型,提供了证据表明,通常对神经元兴奋性产生强大稳定作用的神经元 K7 通道,在 DRG 神经元的异常过度兴奋以及与 DPNP 相关的疼痛敏化中发挥作用。在本免疫组织化学研究中,我们试图确定 K7.2 和/或 K7.5 通道表达是否在 STZ 大鼠的 DRG 神经元中发生改变。我们发现,在 STZ 后 35 天:(1)IB4 阳性和 IB4 阴性的小(<30 µm)DRG 神经元和中等大小(30-40 µm)神经元中 K7.5 免疫反应性显著降低;(2)小(<30 µm)神经元中 K7.2 免疫反应性显著增加,中/大神经元中无显著增加。STZ 大鼠小和中等大小 DRG 神经元中 K7.5 通道表达的减少可能有助于这些神经元过度兴奋的机制,并由此导致与 DPNP 相关的疼痛敏化。小 DRG 神经元中 K7.2 亚基的上调可能是一种依赖于活性的补偿机制,以限制 STZ 诱导的 DRG 神经元过度兴奋和相关的疼痛敏化。这些发现支持 K7 通道可能代表 DPNP 治疗的新靶点的观点。